Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-29T01:30:15.227Z Has data issue: false hasContentIssue false

A New Therapeutic Target for the Treatment of Multiple Sclerosis

Published online by Cambridge University Press:  02 December 2014

Michael O. Poulter*
Affiliation:
Molecular Brain Research Group, Robarts Research Institute, Dept of Physiology & Pharmacology, Faculty of Medicine, University of Western Ontario, London, Ontario, Canada
*
Molecular Brain Research Group, Robarts Research Institute, Dept of Physiology & Pharmacology, Faculty of Medicine, University of Western Ontario, 100 Perth Drive, London, Ontario, n6a 5K8, Canada. email: mpoulter@robarts.ca
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Translational Neuroscience
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Dann, A, Poeck, H, Croxford, AL, et al.Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat Neurosci. 2011;15:98106.Google Scholar